# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001171843-18-002576
Filing Date
2018-04-06
Accepted
2018-04-06 16:06:19
Documents
5
Period of Report
2018-05-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | pre14a_040518.htm | PRE 14A | 970715
2 | GRAPHIC | logo.jpg | GRAPHIC | 6888
3 | GRAPHIC | cheung_sig.jpg | GRAPHIC | 2554
4 | GRAPHIC | proxycard_1.jpg | GRAPHIC | 275521
5 | GRAPHIC | proxycard_2.jpg | GRAPHIC | 161590
| Complete submission text file | 0001171843-18-002576.txt |  | 1587524

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14027 | Film No.: 18743269
SIC: 3841 Surgical & Medical Instruments & Apparatus